MORF
Price
$27.97
Change
+$0.70 (+2.57%)
Updated
May 1, 6:59 PM EST
91 days until earnings call
VIR
Price
$8.74
Change
+$0.28 (+3.31%)
Updated
May 1, 6:59 PM EST
One day until earnings call
Ad is loading...

Analysis and predictions MORF vs VIR

Header iconMORF vs VIR Comparison
Open Charts MORF vs VIRBanner chart's image
Morphic Holding
Price$27.97
Change+$0.70 (+2.57%)
Volume$333.59K
CapitalizationN/A
Vir Biotechnology
Price$8.74
Change+$0.28 (+3.31%)
Volume$1.06M
CapitalizationN/A
View a ticker or compare two or three
MORF vs VIR Comparison Chart

Loading...

MORFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VIRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
MORF vs. VIR commentary
May 01, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MORF is a StrongSell and VIR is a Hold.

COMPARISON
Comparison
May 01, 2024
Stock price -- (MORF: $27.27 vs. VIR: $8.46)
Brand notoriety: MORF and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MORF: 80% vs. VIR: 115%
Market capitalization -- MORF: $1.37B vs. VIR: $1.15B
MORF [@Biotechnology] is valued at $1.37B. VIR’s [@Biotechnology] market capitalization is $1.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $566.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MORF’s FA Score shows that 0 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • MORF’s FA Score: 0 green, 5 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than MORF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MORF’s TA Score shows that 5 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • MORF’s TA Score: 5 bullish, 5 bearish.
  • VIR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both MORF and VIR are a good buy in the short-term.

Price Growth

MORF (@Biotechnology) experienced а -5.15% price change this week, while VIR (@Biotechnology) price change was +4.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.37%. For the same industry, the average monthly price growth was -4.20%, and the average quarterly price growth was +1241.07%.

Reported Earning Dates

MORF is expected to report earnings on Jul 31, 2024.

VIR is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (+3.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MORF with price predictions.
OPEN
A.I.dvisor published
a Summary for VIR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MORF($1.37B) has a higher market cap than VIR($1.15B). MORF YTD gains are higher at: -5.575 vs. VIR (-15.905).
MORFVIRMORF / VIR
Capitalization1.37B1.15B119%
EBITDAN/AN/A-
Gain YTD-5.575-15.90535%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
MORFVIR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
MORFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VIRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EDIIX10.60-0.11
-1.03%
Eaton Vance Global Income Builder I
FGSRX128.61-1.72
-1.32%
Franklin Growth R
ARYDX11.71-0.16
-1.35%
American Century Global Real Estate R6
HISVX37.06-0.62
-1.65%
Harbor Small Cap Value Investor
LFGFX26.94-0.52
-1.89%
Lord Abbett Focused Growth F

MORF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MORF has been loosely correlated with ORMP. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MORF jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MORF
1D Price
Change %
MORF100%
-2.50%
ORMP - MORF
45%
Loosely correlated
-4.72%
AXON - MORF
43%
Loosely correlated
+0.11%
ARRY - MORF
42%
Loosely correlated
-1.52%
SRPT - MORF
42%
Loosely correlated
-1.66%
EDIT - MORF
41%
Loosely correlated
-2.98%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
+1.08%
AXON - VIR
47%
Loosely correlated
+0.11%
GOSS - VIR
44%
Loosely correlated
+1.97%
MORF - VIR
38%
Loosely correlated
-2.50%
MDGL - VIR
36%
Loosely correlated
+1.47%
NTLA - VIR
36%
Loosely correlated
-2.64%
More